trending Market Intelligence /marketintelligence/en/news-insights/trending/Ygfc_Gq_Vkwtx5L_LBFNdg2 content esgSubNav
In This List

Alliqua BioMedical prices $3.8M stock offering

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Alliqua BioMedical prices $3.8M stock offering

Alliqua BioMedical Inc. priced its previously announced underwritten public offering of 9,375,000 common shares at 40 cents per share to raise approximately $3.8 million in gross proceeds.

The company plans to use the net proceeds to meet its debt obligations to Perceptive Credit Opportunities Fund LP. Funds raised will also be used for working capital and general corporate purposes.

Rodman & Renshaw, a unit of H.C. Wainwright and Co., is acting as the sole underwriter for the offering, which is expected to close April 3.